VivoSim Labs, Inc. VIVS
0.13 USD -0.01 (-9.32%)
At closeNov 10, 2026, 4:00 PM EST
0.14 +0.01 +5.56%
After hours · Nov 10, 4:00 PM ET
0.124 Day range 0.149
0.124 52-week range 3.40
- YTD
- -92.85%
- 1 year
- -94.30%
News
benzinga.com VivoSim Labs Partners With Chemveda Life Sciences To Test, Screen AI-Derived Drug Compounds In VivoSim's NAMkind 3D Tissue Models VivoSim Labs, Inc. (Nasdaq: VIVS) ("VivoSim" or "Company"), a provider of AI-enabled New Approach Methodologies (NAMs) for preclinical safety, and Chemveda Life Sciences ("Chemveda"), an
globenewswire.com VivoSim Labs and Chemveda Life Sciences Join Forces to Put AI-Designed Drug Candidates to the Human Test Collaboration closes the loop between AI drug design and human biology: Chemveda designs and makes the molecules, VivoSim's NAMkind™ 3D human liver and intestine models show which ones are safe to…
benzinga.com VivoSim Labs To Extend Its Human Tissue Platform Beyond Toxicology With Efficacy Testing Services Built On NAMkind Disease Models Of The Liver And Intestine The disease models are built with cells from patient donors, so they carry features of the disease itself. Drug developers can measure whether a candidate acts on those disease features in human…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Biomea Fusion (NASDAQ:BMEA) stock increased by 11.0% to $1.51 during Monday's after-market session. The market value of their outstanding shares is at $102.9 million. iTonic Holdings…
benzinga.com Vivosim Labs Notes FDA's Direct Final Rule Clarifying That Non-Animal Methods Can Be Used Where Appropriate For Testing Safety Of Drugs And Biological Products For Human Use The FDA’s new rule replaces the term "animal tests" with "nonclinical tests" across its regulatory framework, formally opening pathways for NAMs, including human cell-based tests such as those…
benzinga.com VivoSim Labs Plans To Develop Rat Liver Model To Complement Existing NAMkind Human Liver Platform And Expand Its Liver Toxicology Capabilities VivoSim Labs, Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced plans to
benzinga.com Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket Avalon Holdings (NYSE:AWX) shares rose 10.5% in pre-market trading after posting strong Q2 earnings of 23 cents per share and sales of $20.898 million. Other stocks gaining pre-market include…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Replimune Group (NASDAQ:REPL) shares increased by 134.6% to $12.69 during Friday's pre-market session. Moleculin Biotech (NASDAQ:MBRX) shares increased by 17.64% to $1.2. The market value of…- benzinga.com VivoSim Labs Announces First Commercial Sales In China For Its NAMkind Testing Services , Inc. (NASDAQ:VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in China, opening…
benzinga.com Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket Callan JMB Inc (CJMB) shares jumped 63.8% in pre-market trading after announcing a strategic partnership with Alabama State University.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's regular session. The company's market cap stands at $7.6 million. Agape ATP (NASDAQ:ATPC) shares moved…
benzinga.com Why Is VivoSim Labs Stock Falling Thursday? VivoSim Labs (VIVS) stock plunges over 25% on a $4M private placement priced at $0.85/share. Read about the dilutive offering.
benzinga.com VivoSim Labs Prices ~$4M Private Placement Of Common Stock, Pre-Funded Warrants At Combined Price Of $0.85/Share, Accompanying Warrant VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced that it…
benzinga.com Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7.9% in pre-market trading. Other top gainers include ATPC, TGHL, ATAI, DXST, KAPA, EHGO, HELP, VSA,…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday's regular session. The market value of their outstanding shares is at $24.9 million. Conexeu Sciences…
benzinga.com Why Vivosim Labs Shares Are Rocketing on Wednesday? VivoSim Labs shares climbed after receiving a $5 million Eli Lilly milestone payment and forecasting more than 500% revenue growth in FY2027.
benzinga.com VivoSim Labs Anticipates 500% Revenue Growth In FY27; Receives $5M Milestone Payment From Eli Lilly VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 134.0% to $7.44 during Thursday's pre-market session. The company's market cap stands at $2.5 million. Alnylam Pharmaceuticals…
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 34.7% to $0.96 during Tuesday's after-market session. The company's market cap stands at $2.0 million. Ironwood Pharmaceuticals…
benzinga.com VivoSim Labs To Present Data Demonstrating Its 3D Human Tissue Models In Two Presentations At The European Society Of Toxicology Annual Conference The presentations collectively showcase the best-in-industry predictive power of VivoSim's proprietary AI-enabled NAMkind™ Liver and NAMkind™ GI platforms. In liver toxicology testing, across a set…- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com VivoSim Labs Announces The Pricing Of Up To A $4M Best-Efforts Public Offering, With $3M Funded At An Initial Closing Of The Offering VivoSim Labs, Inc. (NASDAQ:VIVS), (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the pricing of up to a $4…
- benzinga.com VivoSim Labs Announces Its NAMkind Liver, Intestine Models Validated For Predicting Toxicity, Side Effect Profiles Of Antibody Drug Conjugates VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced at the Society of Toxicology…
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Gold Tumbles Over 6%; Apple Posts Upbeat Earnings 
benzinga.com Dow Falls Over 100 Points; Verizon Earnings Top Views - benzinga.com Market-Moving News for January 30th SNDK: 22% | Sandisk shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 guidance above estimates. CVX: -1% | Chevron Reports Earnings
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Why SanDisk Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - benzinga.com VivoSim Labs Signs JCBio As Authorized Distributor In Korea, Tekon Biotech In China For NAMKind Toxicology Services In Liver, Small Intestine VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company" or "VivoSim Labs"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced it has signed JCBio as an…
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com VivoSim Labs Q1 EPS $(1.14) Up From $(2.76) YoY, Sales $37.000K Down From $39.000K YoY VivoSim Labs (NASDAQ:VIVS) reported quarterly losses of $(1.14) per share. This is a 58.7 percent increase over losses of $(2.76) per share from the same period last year. The company reported…
- benzinga.com Vivosim Labs Announces That It Has Emerged From Stealth Mode To Impact Drug Discovery And Development. Will Offer Liver And Intestinal Toxicology Insights Using Its New Approach Methodologies Models VivoSim Labs, Inc. (NASDAQ:VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.VivoSim will offer liver and intestinal…